32
Participants
Start Date
October 28, 2025
Primary Completion Date
December 1, 2030
Study Completion Date
December 1, 2040
Surgical resection
Planned surgical resection (all participants) 4 weeks after completion of the preoperative RT
Preoperative RT
Preoperative RT at escalating doses in daily fractions over approximately 2-3 weeks; 2 weeks (DL1), or 3 weeks (DL2 or DL3) based on assigned Cohort and Dose Level (DL). Cohorts are by mitotane status at enrollment: Cohort 1 (with detectable mitotane levels), Cohort 2 (never had or without detectable mitotane levels), Cohort 3 (either).
RECRUITING
National Institutes of Health Clinical Center, Bethesda
National Cancer Institute (NCI)
NIH